Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fortress Biotech (FBIO) Depreciation & Amortization (IS) (2016 - 2018)

Historic Depreciation & Amortization (IS) for Fortress Biotech (FBIO) over the last 3 years, with Q3 2018 value amounting to $871000.0.

  • Fortress Biotech's Depreciation & Amortization (IS) rose 7179.49% to $871000.0 in Q3 2018 from the same period last year, while for Sep 2018 it was $3.2 million, marking a year-over-year increase of 5369.29%. This contributed to the annual value of $2.1 million for FY2017, which is 28330.28% up from last year.
  • Per Fortress Biotech's latest filing, its Depreciation & Amortization (IS) stood at $871000.0 for Q3 2018, which was up 7179.49% from $857000.0 recorded in Q2 2018.
  • Fortress Biotech's Depreciation & Amortization (IS)'s 5-year high stood at $871000.0 during Q3 2018, with a 5-year trough of $500000.0 in Q2 2017.
  • In the last 3 years, Fortress Biotech's Depreciation & Amortization (IS) had a median value of $560500.0 in 2016 and averaged $652625.0.
  • In the last 5 years, Fortress Biotech's Depreciation & Amortization (IS) skyrocketed by 568.81% in 2017 and then soared by 7179.49% in 2018.
  • Over the past 3 years, Fortress Biotech's Depreciation & Amortization (IS) (Quarter) stood at $545000.0 in 2016, then grew by 5.69% to $576000.0 in 2017, then soared by 51.22% to $871000.0 in 2018.
  • Its Depreciation & Amortization (IS) stands at $871000.0 for Q3 2018, versus $857000.0 for Q2 2018 and $859000.0 for Q1 2018.